Hctz and Tremfya drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hctz and Tremfya. Common interactions include drug ineffective among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people who take Hctz and Tremfya have. It is created by eHealthMe based on reports of 11 people who take Hctz and Tremfya from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 06, 2023

11 people who take Hctz and Tremfya together, and have interactions are studied.


What is Hctz?

Hctz has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 24,467 Hctz users for its effectiveness, alternative drugs and more.

What is Tremfya?

Tremfya has active ingredients of guselkumab. eHealthMe is studying from 12,073 Tremfya users for its effectiveness, alternative drugs and more.

Number of Hctz and Tremfya reports submitted per year:

Hctz and Tremfya drug interactions.

Common Hctz and Tremfya drug interactions by gender *:

female:

  1. Drug ineffective
  2. Adenocarcinoma
  3. Appendicitis
  4. Arthralgia
  5. Dyspnoea exertional
  6. Lower respiratory tract infection
  7. Peripheral swelling
  8. Weight increased
  9. Psoriasis
  10. Cellulitis

male:

  1. Dyspnoea
  2. Headache
  3. Laryngitis
  4. Nasopharyngitis
  5. Pyrexia
  6. Respiratory failure
  7. Swollen tongue
  8. Toothache

Common Hctz and Tremfya drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Adenocarcinoma
  2. Appendicitis
  3. Psoriasis

50-59:

  1. Psoriasis
  2. Drug ineffective

60+:

  1. Dyspnoea
  2. Cellulitis
  3. Laryngitis
  4. Nasopharyngitis
  5. Pyrexia
  6. Respiratory failure
  7. Swollen tongue
  8. Toothache

Common conditions people have *:

  1. Psoriasis (immune-mediated disease that affects the skin): 6 people, 54.55%
  2. Pustular Psoriasis (raised bumps on the skin that are filled with pus): 2 people, 18.18%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 18.18%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
  5. Diabetes: 1 person, 9.09%
  6. Asthma: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Hctz and Tremfya?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Hctz and Tremfya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Hctz side effects:

Browse all side effects of Hctz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tremfya side effects:

Browse all side effects of Tremfya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Hctz interactions:

Browse all interactions between Hctz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tremfya interactions:

Browse all interactions between Tremfya and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide and guselkumab (the active ingredients of Hctz and Tremfya, respectively), and Hctz and Tremfya (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Hctz and Tremfya.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: